Press releases
- Masimo Provides Facts, Exposes False Narratives in Response to Latest Politan Fictions
- Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
- Masimo Announces Sleep Halo™, Advanced Sleep Analysis for the Masimo W1®
- Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care
- Masimo Files Investor Presentation Highlighting Innovation-Driven Value, Strategic Initiatives to Deliver Robust Growth and Margin Expansion and Risks of Ceding Control to Politan
- Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company’s Full Potential
- Masimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders
- Masimo to Present in Goldman Sachs 45th Annual Global Healthcare Conference
- Masimo Joins Forces with the Mobilize Recovery 2024 Bus Tour
- Politan Files Preliminary Proxy Statement
More ▼
Key statistics
On Friday, Masimo Corp (M2AS34:SAO) closed at 24.48, -3.01% below its 52-week high of 25.24, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.48 |
---|---|
High | 24.48 |
Low | 24.48 |
Bid | 20.84 |
Offer | 20.96 |
Previous close | 23.72 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 05 2024 20:54 BST.
More ▼